ResearcherYamaguchi UniversityActive in the last 2 years
Kimikazu Hamano
Matched on ORCID iD 0000-0003-3455-7248; OpenAlex author ID A5105350671. Sources: OpenAlex.
Their work
- Papers
- 4 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2017: 1 paper · 2018: none · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper
Papers 4
- Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospective Multi-Center Analysis (YPB-003). Co-author DOI 10.1002/cam4.70647↗
- Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). Co-author DOI 10.1097/mpa.0000000000002323↗
- [Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture]. Co-author PMID 32156955↗
- Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells. Last author DOI 10.3892/or.2017.5974↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoshitaro Shindo · 3 shared papers, 2019–2025 · strength 0.45
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Paper [Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture]. PMID 32156955↗
- Hiroaki Nagano · 3 shared papers, 2019–2025 · strength 0.45
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Paper [Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture]. PMID 32156955↗
- Hiroto Matsui Matsui · 3 shared papers, 2019–2025 · strength 0.45
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Paper [Five Cases of Ten-Year Survival after Surgical Treatment of Pancreatic Cancer in Yamaguchi Prefecture]. PMID 32156955↗
- Tatsuya Ioka · 2 shared papers, 2024–2025 · strength 0.37
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Masao Nakajima · 2 shared papers, 2024–2025 · strength 0.37
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Taro Takami · 2 shared papers, 2024–2025 · strength 0.37
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Hidekazu Tanaka · 2 shared papers, 2024–2025 · strength 0.37
- Paper Survival Analysis of 4 Different Age Groups of Pancreatic Ductal Adenocarcinoma After Radical Resection From Retrospect… DOI 10.1002/cam4.70647↗
- Paper Multicenter Prospective Cohort Study of Neoadjuvant Chemotherapy for Borderline Resectable Pancreatic Cancer (YPB-001). DOI 10.1097/mpa.0000000000002323↗
- Katsuyoshi Ito · 2 shared papers, 2019–2024 · strength 0.25
- Tomio Ueno · 1 shared paper, 2019 · strength 0.08
- Masahiro Tanabe · 1 shared paper, 2019 · strength 0.08
- Yasuhiro Fujiwara · 1 shared paper, 2019 · strength 0.08
- Isao Sakaida · 1 shared paper, 2019 · strength 0.08
- Arata Nishimoto · 1 shared paper, 2017 · strength 0.07
- Daichi Kawamura · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.